Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03236935
Brief Title: Phase Ib of L-NMMA and Pembrolizumab

First Submitted : July 28, 2017
First Submitted that Met QC Criteria : July 28, 2017
First Posted : August 2, 2017

Last Update Submitted that Met QC Criteria : November 26, 2018
Last Update Posted : November 28, 2018